For a company that is putting up solid sales growth, has a great brand, and has seen its stock price rise more than 40% in the last 12 months, Saks (NYSE: SKS ) didn't demand much of a premium. Hudson's Bay, the operator behind Lord & Taylor, picked up Saks for just $16 per share, representing a 4.5% bump to Friday's closing price.
Why is this good news?
It seems like an odd move from Saks' point of view. Hudson's Bay posted a loss in its last quarter, while Saks put up a nice profit in its most recent period. Hudson's Bay also has almost no cash on hand to finance the transaction. The business had about $27 million in cash at its last reporting in May, and it's going to finance the acquisition with equity, debt, and secured notes.
You know what, speaking of the word "acquisition," let's call this what it really is -- a merger. Saks has a larger market capitalization, and while Hudson's Bay runs substantially more locations, it only barely edged out Saks in total revenue last quarter.
Top 5 Consumer Service Companies To Buy Right Now: Oclaro Inc.(OCLR)
Oclaro, Inc. offers optical network components, modules, and subsystems to telecommunications equipment manufacturers. The company designs, manufactures, and markets products that generate, detect, amplify, combine, and separate light signals in telecommunications networks. It offers tunable laser products that include discrete lasers and co-packaged laser modulators; fixed laser products comprising discrete lasers and co-packaged laser modulators; lithium niobate external modulators; a portfolio of discrete receivers for metro and long-haul applications; small form factor pluggable transceivers; and transponder modules, which provide transmitter and receiver functions. Oclaro also provides Erbium doped fiber amplifiers, semi-custom product portfolio of multi-wavelength amplifiers, and narrow band mini-amplifiers; pump laser chips; and wavelength management products, including switching and routing solutions, multiplexing and signal processing solutions, and micro-optics a nd integrated modules. In addition, it offers dispersion compensation product family consisting of products that optically compensate for chromatic dispersion and dispersion degradation of transmission signals, including fixed and tunable products based on dispersion compensating fiber and cascaded etalons; and thin film filter products used for multiplexing and demultiplexing optical signals within dense WDM transmission systems, as well as markets advanced pump laser technology diodes. Further, the company sells low-power polarized products for optical mouse and finger navigation applications. It markets its products through direct sales and marketing organization, sales representatives, and resellers in Canada, China, France, Germany, Italy, Switzerland, the United Kingdom, Japan, and the United States. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, Cali fornia.
Advisors' Opinion:- [By Lisa Levin]
Oclaro (NASDAQ: OCLR) shares touched a new 52-week high of $2.36. Oclaro shares have jumped 71.32% over the past 52 weeks, while the S&P 500 index has gained 31.67% in the same period.
- [By CRWE]
About Oclaro
Oclaro, Inc. (Nasdaq:OCLR) is one of the largest providers of optical components, modules and subsystems for the optical communications market. The company is a global leader dedicated to photonics innovation, with cutting-edge research and development (R&D) and chip fabrication facilities in the U.S., U.K., Italy, Korea and Japan. It has in-house and contract manufacturing sites in China, Malaysia and Thailand, with design, sales and service organizations in most of the major regions around the world. For more information, visit http://www.oclaro.com.
Safe Harbor Statement
Top 5 Consumer Service Companies To Buy Right Now: Giga-tronics Inc (GIGA)
Giga-tronics Incorporated (Giga-tronics), incorporated on March 5, 1980, includes the operations of the Giga-tronics Division and Microsource Inc. (Microsource), a wholly owned subsidiary. Giga-tronics Division designs, manufactures and markets a line of test and measurement equipment used in the development, test and maintenance of wireless communications products and systems, flight navigational equipment, electronic defense systems and automatic testing systems. These products are used primarily in the design, production, repair and maintenance of commercial telecommunications, radar, and electronic warfare equipment. The Company manufactures products used in test, measurement and control. The Company has two segments: Giga-tronics Division and Microsource. In April 2013, it completed the sale of its product line known as SCPM to Teradyne, Inc.
Giga-tronics
The Giga-tronics Division produces signal sources, generators and sweepers, and power measurement instruments for use in the microwave and radio frequency (RF) range (10 kilohertz (kHz) to 50 gigahertz (GHz)). Within each product line are a number of different models and options allowing customers to select frequency range and specialized capabilities, features and functions. The end-user markets for these products can be divided into three segments: commercial telecommunications, radar and electronic warfare. These instruments are used in the design, production, repair and maintenance and calibration of other manufacturers' products, from discrete components to complex systems.
The Giga-tronics Division also produces switch modules and interface adapters that operates with a bandwidth from direct current (DC) to optical frequencies. These switch modules may be incorporated within its customers' automated test equipment. The end-user markets for these products are primarily related to defense, aeronautics, communications, satellite and electronic warfare, commercial aviation and semiconductors.
The Microsource segment develops and manufactures a broad line of yttrium, iron, garnet (YIG) tuned oscillators, filters and microwave synthesizers, which are used by its customers in operational applications and in manufacturing a variety of microwave instruments or devices.
Giga-tronics competes with Agilent, Anritsu, EADS, Aeroflex and Rohde & Schwarz.
Advisors' Opinion:- [By Monica Gerson]
Giga-tronics (NASDAQ: GIGA) dropped 14.84% to $1.32. Giga-tronics' trailing-twelve-month profit margin is -30.58%.
MER Telemanagement Solutions (NASDAQ: MTSL) dropped 14.62% to $2.09 after the company terminated MVNE solution provider agreement with SBC Communications.
10 Best Japanese Stocks To Own Right Now: Gamestop Corporation (GME)
GameStop Corp. operates as a retailer of video game products and personal computer (PC) entertainment software. It sells new and used video game hardware; video game software; used video game products; and video game accessories, which primarily consist of controllers, memory cards, and other add-ons, as well as strategy guides and trading cards. The company also offers PC entertainment and other software across various genres, including sports, action, strategy, adventure/role playing, and simulation, as well as products that relate to the digital category comprising network point cards, prepaid digital and online timecards, and digitally downloadable software. GameStop Corp. sells its products through stores, as well as through its electronic commerce Web sites, including gamestop.com, ebgames.com.au, gamestop.ca, gamestop.it, gamestop.es, gamestop.ie, gamestop.de, and micromania.fr. As of July 12, 2011, its retail network and family of brands included 6,573 company-oper ated stores in 17 countries worldwide. The company also publishes Game Informer, a video game magazine in the United States; and operates the online video gaming Web sites kongregate.com and joltonline.com. GameStop Corp. was founded in 1994 and is based in Grapevine, Texas.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of GameStop (NYSE: GME) were down 20.62 percent to $36.17 after the company cut its profit outlook for the holiday quarter.
Top 5 Consumer Service Companies To Buy Right Now: Furiex Pharmaceuticals Inc (FURX)
Furiex Pharmaceuticals, Inc. is a drug development collaboration company. The Company�� product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. Its programs include Priligy, Alogliptin Nesina, Alogliptin/Actose Combination, Alogliptin/Metformin Combination, Fluoroquinolone, Mu Delta and PPD 10558. In November 2011, it acquired full exclusive license rights to develop and commercialize the compound MuDelta under its existing development and license agreement with Janssen Pharmaceutica N.V.
Priligy (dapoxetine) is a drug developed for the on-demand treatment of premature ejaculation (PE). Dapoxetine is a short-acting, selective serotonin reuptake inhibitor (SSRI) designed to be taken only when needed one to three hours before sexual intercourse is anticipated rather than every day. Nesina (alogliptin) is a drug for the oral treatment of type 2 diabetes (T2D). Alogliptin is a DPP-4 inhibitor that slows the inactivation of incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP).
Fluoroquinolone drug candidate is a Phase II-ready novel fluoroquinolone antibiotic that is being developed by the Company for the treatment of complicated skin and skin structure infections, such as abscesses that occur deep in the skin layers and respiratory infections. This antibiotic has a spectrum of activity and is able to treat methicillin-resistant staphylococcus aureus (MRSA) infections. The Company is developing both oral and intravenous (IV) formulations. The Company is developing Mu Delta for treatment of diarrheal predominant irritable bowel syndrome (d-IBS). The Company is conducting a Phase II study on an oral formulation of Mu Delta.
The Company is developing PPD 10558 for the treatment of dyslipidemia. PPD 10558 has shown muscle safety in preclinical studies by minimizing the delivery of the drug to the muscle. The Company has filed an inve! stigational new drug (IND) application with the United States Food and Drug Association and completed five clinical studies.
Advisors' Opinion:- [By John Udovich]
Yesterday, small cap drug development collaboration company Furiex Pharmaceuticals Inc (NASDAQ: FURX) surged 129.91% after announcing that its experimental drug had alleviated diarrhea and abdominal pain caused by irritable bowel syndrome in two studies, meaning its worth taking a closer look at the stock because that�� a condition that effects millions of people (with no other effective drug to treat it) plus take a look at the�performance of biotech benchmarks iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
- [By Lauren Pollock var popups = dojo.query(".socialByline .popC"); popups.forEach]
Forest Laboratories Inc.(FRX) agreed to acquire Furiex Pharmaceuticals(FURX) in a deal worth up to $1.33 billion that expands Forest Labs’ presence in gastroenterology. Furiex surged 28% to $102.21 premarket.
- [By Lisa Levin]
Furiex Pharmaceuticals (NASDAQ: FURX) shares moved up 28.41% to $102.92. The volume of Furiex Pharmaceuticals shares traded was 2285% higher than normal. Forest Labs (NYSE: FRX) announced its plans to buy Furiex Pharma for up to $1.46 billion.
Top 5 Consumer Service Companies To Buy Right Now: Fonar Corporation(FONR)
FONAR Corporation engages in the research, development, production, marketing, and service of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases. It provides Upright Multi-positional MRI scanners, which allow patients to be scanned in a weight-bearing condition, such as standing, sitting, or bending in any position that causes symptoms; and FONAR 360 MRI scanner, a diagnostic scanner. The company, through its wholly owned subsidiary, Health Management Corporation of America, also offers management services to imaging facilities, including development, administration, and leasing of office space, facilities, and medical equipment; provision of supplies; staffing, training, and supervision of non-medical personnel; legal services; accounting, billing, and collection; and the development and implementation of practice growth and marketing strategies. It serves private diagnostic imaging centers and hospitals. As of June 30, 2011, the c ompany managed 10 diagnostic imaging facilities located in the states of New York and Florida. FONAR Corporation was founded in 1978 and is based in Melville, New York.
Advisors' Opinion:- [By Monica Gerson]
Breaking news
NASDAQ OMX Group (Nasdaq: NDAQ) and Borsa Istanbul A.S. have today concluded a wide-ranging agreement, which includes the delivery of market-leading technologies and advisory services to Borsa Istanbul, and NASDAQ OMX taking an equity stake in Borsa Istanbul. To read the full news, click here. Acacia Research (NASDAQ: ACTG) announced today that its Bolt MRI Technologies LLC subsidiary has entered into an agreement with Fonar Corporation (NASDAQ: FONR). To read the full news, click here. Douglas Emmett, (NYSE: DEI) announced that William Kamer will be retiring from full time service as its Chief Investment Officer effective January 31, 2014. Mr. Kamer will continue to be employed by Douglas Emmett as a Senior Advisor. To read the full news, click here. Acacia Research (NASDAQ: ACTG) announced today that its Brandywine Communications Technologies LLC subsidiary has entered into a settlement and patent license agreement with Alcatel-Lucent USA (NYSE: ALU). To read the full news, click here.Posted-In: Benchmark US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
No comments:
Post a Comment